Interestingly, PARP3 has been associated with promoting chromosomal rearrangements, limiting G4 DNA structures, and enhancing breast cancer aggressiveness, pointing to its selective inhibition as a potential therapeutic strategy in oncology46. This evidence concerns the gene PARP3 and breast cancer.